Zohydro Approval Status beta

  • FDA approved: No
  • Brand name: Zohydro
  • Generic name: hydrocodone
  • Company: Zogenix, Inc.
  • Treatment for: Pain

Zohydro ER (hydrocodone) is a single-entity (without acetaminophen) extended-release opioid analgesic for around the clock management of moderate to severe chronic pain.

FDA Approval Status for Zohydro

DateArticle
Feb 27, 2013Zogenix Provides Update on Zohydro ER Regulatory Review
Dec 10, 2012Zogenix Provides Update on FDA Advisory Committee Meeting for Zohydro ER for Management of Chronic Pain
Nov 16, 2012Zogenix Announces FDA Advisory Committee Review of Zohydro ER for the Management of Chronic Pain
Jul 16, 2012Zogenix Announces U.S. Food and Drug Administration (FDA) Acceptance for Review of Zohydro ER New Drug Application (NDA) for Treatment of Chronic Pain
May  2, 2012Zogenix Submits New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Zohydro for Treatment of Chronic Pain

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Suffering from knee pain? Find out how real people manage OA of the Knee. Watch Video

Close
(web1)